Acutus Medical, Inc.

Equities

AFIB

US0051111096

Medical Equipment, Supplies & Distribution

Delayed OTC Markets 09:53:15 2024-05-22 am EDT 5-day change 1st Jan Change
0.0556 USD -1.58% Intraday chart for Acutus Medical, Inc. +15.59% -72.46%

This article is reserved for members

Already a member?

Log In

Not a member ?

Free registration
Acutus Medical, Inc.(NasdaqCM:AFIB) dropped from S&P TMI Index CI
Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q1 Continuing Operations Revenue $3.6M MT
Acutus Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 CI
Acutus Medical, Inc.(NasdaqCM:AFIB) dropped from NASDAQ Composite Index CI
North American Morning Briefing : Focus Turns to -2- DJ
Acutus Medical, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
BIOTRONIK SE & Co. KG Announces Termination of Bi-Lateral Distribution Agreements with Acutus Medical, Inc CI
Wall Street Set to Open Marginally Lower Friday; December Inflation Data Lower Than Forecast MT
Acutus Medical, Inc. Announces Board Changes CI
Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q3 Revenue $5.2M, vs. Street Est of $4.8M MT
Acutus Medical, Inc. Announces Chief Executive Officer Changes CI
Acutus Medical, Inc. Announces Management Resignations CI
Acutus Medical, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023 CI
Transcript : Acutus Medical, Inc., Q2 2023 Earnings Call, Aug 07, 2023
Earnings Flash (AFIB) ACUTUS MEDICAL Reports Q2 Revenue $5.3M, vs. Street Est of $4.5M MT
Acutus Medical, Inc. Provides Revenue Guidance for the Year 2023 CI
Acutus Medical, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023 CI
Acutus Medical, Inc. Announces Executive Changes CI
Acutus Medical, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2023 CI
Transcript : Acutus Medical, Inc., Q1 2023 Earnings Call, May 11, 2023
Earnings Flash (AFIB) ACUTUS MEDICAL Posts Q1 Revenue $4.2M MT
Acutus Medical, Inc. Provides Revenue Guidance for the Year 2023 CI
Transcript : Acutus Medical, Inc. - Special Call
Acutus Medical, Inc. Provides Revenue Guidance for the First Quarter 2023 CI
Transcript : Acutus Medical, Inc., Q4 2022 Earnings Call, Mar 16, 2023
Chart Acutus Medical, Inc.
More charts
Acutus Medical, Inc. is focused on the production of left-heart access products under its distribution agreement with Medtronic, Inc. (Medtronic). The Company is solely focused on supporting the manufacturing and distribution of products to Medtronic. It manufactures transseptal crossing devices and associated accessories, such as integrated transseptal dilators and needles, fixed-curve or steerable introducers, and steerable sheaths (Products). These Products are used to access the left side, or left atrium, of the cardiac anatomy and are used in a range of medical applications, including in electrophysiology and structural heart procedures. The technology supports physicians during a critical component of an ablation or structural heart procedure. The transseptal crossing devices that it manufactures for Medtronic include versions that are length-, diameter- and tip-matched and designed to lock into the hub of sheaths used in many left-heart procedures.
Calendar
More about the company
  1. Stock Market
  2. Equities
  3. AFIB Stock
  4. News Acutus Medical, Inc.
  5. Sector Update: Health Care Stocks Mixed Pre-Bell Monday
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW